medication-adherence
(17)
ExactCare Put the Pharmacy Counter in a Box - Then Built a Care Team Around It
A Cleveland pharmacist noticed that the hardest part of medicine was often not inventing it, but taking it correctly. ExactCare turned the monthly refill into packaging, logistics and clinical follow-through for people whose pill routines had become a second job.
Danny Sigurdson
Danny Sigurdson is the founder and CEO of Courier Health, a New York-based technology company that builds a purpose-built patient CRM and experience platform for life sciences companies. After more than a decade in enterprise software - including a role as VP of Sales at ActionIQ and client leadership at Applied Predictive Technologies - he started Courier Health in 2020 to close the gap between specialty medicine approvals and the patients who never start or stay on treatment. The company has raised $70.5M to date, most recently a $50M Series B led by Oak HC/FT.
Percipio Health
Percipio Health is a Plano, Texas company that turns an ordinary smartphone into a whole-person health monitor, using AI to read vision- and voice-based biomarkers - vitals, medication adherence, brain health and social determinants - without any dedicated medical devices. Founded by digital-health veterans Eric Rock and David Lucas, the team behind Vivify Health and MEDHOST, the platform helps health plans and providers catch rising-risk and high-risk patients earlier and manage large populations at lower cost. It launched publicly in January 2025 alongside a $20M Series A led by UPMC Enterprises, WAVE Ventures and Labcorp.
Chronica
Chronica is a San Diego digital-health company that runs remote patient monitoring (RPM) and chronic care management (CCM) as a managed service. Built on parent company Hifinite Health's hiCare platform, Chronica pairs a cloud-based, HIPAA-compliant software stack with the parts most clinics don't want to build themselves: the connected devices, the in-house clinicians, the call center, and the billing paperwork tied to CMS reimbursement codes. Providers - from outpatient practices to hospitals, ACOs, and home-health agencies - get to extend care beyond the exam room without upfront costs, long contracts, or patient minimums.
GenieMD
GenieMD is a San Ramon, California virtual care company that sells a single, white-label platform folding together telehealth, remote patient monitoring, remote therapeutic monitoring and chronic care management - plus built-in e-prescriptions, lab integration and CPT billing reports. Founded in 2010 by Stanford-trained engineer Soheil Saadat, it sells to hospitals, health systems, group practices, insurers, ACOs and employers, and in 2026 launched HelloGenie, a free AI doctor that hands patients off to real board-certified physicians when actual care is needed. Frost & Sullivan named it 2024 Company of the Year for virtual chronic disease management.
Matthew Loper
Matthew Loper is the co-founder and CEO of Wellth, a Los Angeles digital-health company that pays people small cash rewards for sticking to their care plans. A biological engineer from MIT turned healthcare banker and investor, he built Wellth around behavioral economics rather than technology - the idea that immediate, tangible incentives change what people actually do about their chronic conditions. Under his leadership Wellth has raised more than $73 million, including an oversubscribed $36 million Series C in 2025, and reports steep drops in hospital and emergency-room use among the high-need Medicare and Medicaid populations it serves.
Dan Rubin
Dan Rubin is President and CEO of PARx Solutions, a Burlington, Massachusetts healthtech company that runs the Prior Authorization Support System (PASS), a service that helps physician offices push prescriptions past insurer prior-authorization roadblocks at no cost to the practice. A chemical engineer by training who switched to building businesses, Rubin co-founded medication-adherence pioneer Adheris in 1993, ran it for fifteen years, then took the helm at PARx in 2012. He has spent three decades on a single problem: the gap between a doctor writing a prescription and a patient actually getting the medicine.
BlinkRx
BlinkRx is the enterprise platform of New York-based Blink Health, founded by brothers Geoffrey and Matthew Chaiken. Billed as a 'pharma-to-patient cloud,' it lets pharmaceutical manufacturers run the entire prescription journey - pricing, prior authorization, copay assistance, fulfillment, free home delivery, and adherence support - on a single system. Its consumer side offers cash-pay discounts and an online pharmacy. The company says it supports millions of patients across all 50 states and has raised hundreds of millions in venture funding.
C3 HealthcareRx
C3 HealthcareRx is a North Carolina value-based care company that helps health plans and health systems keep complex, chronically ill patients healthy and out of the hospital. It pairs high-touch medication management and pharmacy services with MindHealthy, a physician-led behavioral health program delivered through the Collaborative Care Model (COCM). After a January 2026 merger with Wellbox Health, the combined organization serves more than 40,000 patients nationwide across five integrated service lines spanning medication, behavioral health, chronic-care coordination, remote patient monitoring, and pharmacy.
Wellth
Wellth is a Los Angeles-based digital health company that uses behavioral economics and small financial incentives to help high-risk patients build daily healthy habits - taking medications, checking vitals, and showing up to appointments. Through a consumer-grade smartphone app built around daily photo check-ins, Wellth works with Medicare Advantage, Medicaid, D-SNP, ACA and employer plans to improve care plan adherence, lift Star Ratings, and lower costly hospital admissions.
Medisafe
Medisafe is a digital health company that turns the everyday struggle of taking pills on time into a behavior-driven engagement platform. Born from a near-fatal insulin overdose in the founders' own family, it began as a free virtual pillbox app and grew into an enterprise platform - anchored by Medisafe Maestro and its Just-in-Time Interventions (JITI) engine - that pharmaceutical companies use to keep patients on therapy. With more than 13 million users worldwide and 4+ billion doses tracked, Medisafe sits at the intersection of consumer mobile health and the multibillion-dollar problem of medication non-adherence.
Yoona Kim
Yoona Kim is the co-founder and CEO of Arine, a San Francisco medication intelligence company she started in 2017 with CTO Penjit 'Boom' Moorhead. A pharmacist and health economist by training, Kim built Arine to attack one of medicine's least glamorous and most expensive problems: people getting the wrong drugs, the wrong doses, and the wrong combinations. Arine's AI platform now touches more than 25 million lives across 40-plus health plan clients, and the company says its work has cut hospitalizations by over 40% for clients while shaving care costs by double digits.
Dave Icke
Dave Icke is the CEO of Medisafe, the medication engagement platform that helps more than ten million patients stay on their treatments. A chemical engineer turned digital-health operator, he has spent two decades turning hardware and software into tools that keep people healthier: founding CEO of wearable biosensor company mc10, launcher of Becton Dickinson's digital health business, VP of Digital Health Product at Humana, and executive chair of mental-health AI company ieso. In 2025 he took the reins at Medisafe from founder Omri Shor to scale medication engagement across the global pharmaceutical ecosystem.
GoodRx
GoodRx is a Santa Monica-based digital healthcare platform that helps Americans find lower prices on prescription drugs. It aggregates real-time pricing and discounts from pharmacies nationwide so consumers can compare costs and access free coupons, then layers on telehealth visits, manufacturer savings programs, and tools for pharma and employers. Since 2011 it has helped tens of millions of people save an estimated $70+ billion on medications.
Hello Heart
Hello Heart is a Menlo Park-based digital health company exclusively focused on cardiovascular health. Founded in 2013, it offers an AI-powered mobile app paired with a connected blood pressure monitor and smart pill box that helps members understand, track, and improve their heart health. Deployed through employers, health plans, and Medicare Advantage programs, Hello Heart has served users at 150+ Fortune 500 companies and government organizations. Independent peer-reviewed studies - including a JAMA study of 28,000+ participants - show that 84% of high-risk users reduced blood pressure over three years, with average medical cost savings exceeding $1,700 per enrolled member per year. The company has raised $148.5 million in total funding, most recently a $70 million Series D in May 2022.
House Rx
House Rx is a San Francisco-based healthcare technology company that partners with specialty clinics to enable medically integrated dispensing (MID) - a model where physicians, pharmacists, nurses, and care coordinators work together as one unified team. Founded in 2021 by Flatiron Health veterans Ogi Kavazovic and Tesh Khullar, the company builds AI-enabled pharmacy management software that keeps specialty medications dispensed at the point of care, cutting average time-to-therapy from 15.5 days to 3.5 days and achieving 95% medication adherence. With $100M raised across Seed, Series A, and Series B rounds, House Rx serves 80 clinic sites, 1,000+ providers, and nearly 61,000 patients, processing approximately $1.5 billion in specialty prescriptions annually.
Ogi Kavazovic
Ogi Kavazovic is the co-founder and CEO of House Rx, a San Francisco-based specialty pharmacy platform that enables clinical practices to dispense specialty medications directly to patients in-house. A serial operator who helped scale Opower (acquired by Oracle) and Flatiron Health (acquired by Roche), Ogi pivoted to fix a problem he kept seeing: patients leaving the doctor's office only to get lost in a broken specialty pharmacy system. House Rx has raised $100 million in total, including a $55 million Series B in November 2025, and now processes approximately $1.5 billion in specialty scripts annually across 80+ clinic sites.